Amarin Corp Plc (AMRN)

[Bouf]

What we know is that AMRN sold Vascepa at an approx. price of $144/script in Q4 2018(539K scripts x $144 = $77 MM).

Retailers like CVS and Walmart are selling the same product for $300-350. (Can’t figure out how to cut and paste an iPhone photo into IHUB, but you can call CVS yourself if you really think I’m lying.)

So there is at least 100% markup from wholesale to retail prices.

I AM NOT SAYING THIS IS INHERENTLY EVIL, despite your characterization of my argument.

I repeat, the point is that drug pricing affects everyone, from the consumer of V to those that pay private insurance premiums and taxes supporting public coverage like Medicare. We all have an interest in this issue, and I applaud the Trump administration for attempting to do something to reign in the growth in these costs. For the same reason that utility costs are regulated (this product is essential to public health and safety), drugs costs have to be controlled reasonably.

Have a good day.